Marrone Bio Innovations, Inc Closes $9.2 Million Public Offering Of Common Stock With Full Exercise Of Over-Allotment Option Post author:Sam Post published:April 30, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Why Intercept Pharma Stock Jumped Nearly 10% On Friday After Providing Phase III Update February 9, 2017 Massachusetts Startup Frequency Therapeutics Nabs $32 Million April 10, 2017 Sonoma Pharma Announces U.S. Commercialization Of Loyon For Relief Of Scaling, Burning And Itching Associated With Various Dermatoses Including Seborrhea And Seborrheic Dermatitis October 2, 2017
Why Intercept Pharma Stock Jumped Nearly 10% On Friday After Providing Phase III Update February 9, 2017
Sonoma Pharma Announces U.S. Commercialization Of Loyon For Relief Of Scaling, Burning And Itching Associated With Various Dermatoses Including Seborrhea And Seborrheic Dermatitis October 2, 2017